Vice President, Finance Planning and Analysis

Vir Biotechnology•San Francisco, CA

4d•$300,000 - $350,000•Hybrid

About The Position

Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Vir Biotechnology has exclusive rights to the universal PRO-XTEN® masking platform for oncology and infectious disease. PRO-XTEN® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company. We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best. Vir Bio is seeking a Vice President of Financial Planning & Analysis to lead enterprise‑wide financial planning and serve as a core member of the Company’s strategic and operational leadership. This role is accountable for driving capital allocation, long‑range financial strategy, and performance management across the organization, with direct impact on enterprise value creation and strategic decision‑making. The VP, FP&A will own the Company’s planning and forecasting architecture, valuation framework, and financial decision support, partnering closely with the executive team, functional leadership, and project teams. This is a highly visible, hands‑on leadership role requiring strong judgment, deep biotech financial expertise, and the ability to translate complexity into clear, actionable recommendations. This role is based in Vir’s San Francisco headquarters with an expectation of at least three days per week in the office.

Requirements

Bachelor’s degree in finance, accounting, or a related discipline, with fifteen or more years of progressive finance leadership experience
Deep experience supporting biotech or pharmaceutical R&D organizations, including development economics and portfolio decision‑making
Demonstrated expertise in valuation, scenario modeling, and capital allocation in complex and uncertain environments
Commercial financial planning expertise in the Biotech or Pharma industry
Proven executive leadership skills, including building and leading teams, influencing senior stakeholders, and partnering cross‑functionally
Strong systems orientation with experience operating sophisticated planning, forecasting, or ERP platforms
Sound knowledge of US GAAP, internal controls, and SOX‑compliant environments

Nice To Haves

MBA and/or CPA, or equivalent advanced credentials strongly preferred

Responsibilities

Lead the enterprise FP&A function, establishing short‑ and long‑term financial plans that align capital deployment with the Company’s highest‑value strategic priorities
Own company‑wide budgeting, forecasting, and long‑range planning processes, with accountability for performance against plan and recommended corrective actions
Serve as a senior finance business partner to executive leadership, providing financial leadership on clinical development, manufacturing, partnerships, commercial and key strategic initiatives
Partner with Accounting on collaboration and partnership financials, including quarter‑end activities, external funding applications, reporting, and partner‑facing budget management
Maintain and continuously refine the Company’s internal valuation and scenario‑modeling framework
Lead, develop, and scale a high‑performing FP&A team responsible for portfolio investment analysis and strategic financial support for R&D
Advance financial analytics, reporting, and systems to support executive, Board, investor, and partner decision‑making along with assisting with internal and business development valuations
Design and implement process and reporting enhancements that improve transparency, discipline, and decision quality